Research article summary (published 29 Apr 2006):

Cancer treatments for the new millennium.

Full Abstract

The SMR Symposium Cancer Treatments for the New Millennium was held on March 9, 2006, at the National Heart and Lung Institute, Imperial College London. The conference program brought together an international line-up of speakers representing academia, biotech and large pharma to discuss the development status of a number of new innovative treatments for the treatment or prevention of cancer. Presentations also focused on how new technologies are being applied to the design of the next generation of cancer drugs and the fundamental biological challenges that must be addressed in attempting to discover effective new treatments.Copyright 2006 Prous Science

Learn Faster Today      Improve your study skills

Author information

Author/s: Williams, Robert (R); Searcey, Mark (M); Potter, Barry (B);

Affiliation: Department of Pharmaceutical and Biological Chemistry, School of Pharmacy, University of London.

Journal and publication information

Publication Type: Congresses

Journal: Drug news & perspectives (Drug News Perspect), published in Spain. (Language: eng)

Reference: 2006-May; vol 19 (issue 4) : pp 229-32

Dates: Created 2006/07/06; Completed 2006/10/12;

PMID: 16823498, status: MEDLINE (last retrieval date: 12/26/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Antineoplastic Agents - therapeutic use Humans

Humans Neoplasms - therapy

Associated Chemicals: Antineoplastic Agents (0)

Related articles

These are the highest related articles currently in the database:

• Ranpirnase (Onconase), a cytotoxic amphibian ribonuclease, manipulates tumour physiological parameters as a selective killer and a potential enhancer for chemotherapy and radiation in cancer therapy. 30 May 2008
• Polynucleotide kinase as a potential target for enhancing cytotoxicity by ionizing radiation and topoisomerase I inhibitors. 29 Apr 2008
• Tumor cell metabolism: cancer's Achilles' heel. 30 May 2008
• [Ethnic differences of genetic polymorphisms in cancer chemotherapy] 29 Jun 2008
• Modulation of cellular response to anticancer treatment by caffeine: inhibition of cell cycle checkpoints, DNA repair and more. 30 Jul 2008
• Recent advances in Hsp90 inhibitors as antitumor agents. 29 Sep 2008
• Flavonoids as RTK inhibitors and potential anticancer agents. 30 Aug 2008
• Targeting base excision repair for chemosensitization. 29 Apr 2008
• DNA repair proteins as molecular targets for cancer therapeutics. 29 Apr 2008
• The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. 29 Apr 2008

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.